Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2019 Sep 3;38(47):7279–7280. doi: 10.1038/s41388-019-0896-1

Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer

Linjie Zhao 1,#, Wei Wang 2,#, Lian Xu #, Tao Yi 1, Xia Zhao 1, Yuquan Wei 1, Louis Vermeulen, Ajay Goel, Shengtao Zhou 1,, Xin Wang 2,
PMCID: PMC7609282  PMID: 31481747

Correction to: Oncogene

10.1038/s41388-018-0577-5 published online 26 November 2018

Following publication of this article, the authors noted that they accidentally misplaced the figure in supplementary Fig. 7b when re-editing the figures to meet the format and the image resolution of the journal. The amended version of supplementary Fig. 7 is provided below. This change does not affect the results or conclusions reported in the paper.

Fig. S7.

Fig. S7

a Transwell chamber analysis of control or LOX silenced OV56 cells transfected with miR-508-3p inhibitor. b Transwell chamber analysis of control or LOX-overexpressing COV504 cells transfected with miR-508-3p mimic. In all bar plots, p-values are based on two-tailed Student's t-tests (*P < 0.05, **P < 0.01, ***P < 0.001)

Footnotes

The original article can be found online at 10.1038/s41388-018-0577-5.

These authors contributed equally: Linjie Zhao, Wei Wang, Lian Xu

Contributor Information

Shengtao Zhou, Email: taotaovip2005@163.com.

Xin Wang, Email: xin.wang@cityu.edu.hk.


Articles from Oncogene are provided here courtesy of Nature Publishing Group

RESOURCES